A woman, from Ridgeway, Virginia, has claimed that taking Zantac daily for years caused her esophageal cancer.
Deborah Haskins has filed a lawsuit against the makers of heartburn medication Zantac in the US District Court for the District of New Jersey.
Haskins began using Zantac in 2005 and took at least one tablet of 75mg every day. She claimed that it caused her esophageal cancer.
However, it is not known when she was diagnosed.
Haskins said that Zantac’s active ingredient, ranitidine, can produce the cancer-causing agent NDMA.
She has accused Zantac of failing to warn consumers of the risks. She said she would have never purchased the medication if the risks of the medication were known to her.
Haskins is seeking an undisclosed amount for damages, including medical expenses, lost wages, and ‘loss of enjoyment of life.’
The lawsuit states: “As a direct and proximate result of ingesting Zantac, Plaintiff contracted Esophageal Cancer. Had Plaintiff been informed that taking Zantac would expose her to unsafe quantities of NDMA such that it could and did cause her to contract Esophageal Cancer, she never would have purchased or ingested Zantac.”
Dozens of similar Zantac cancer lawsuits have been filed in recent months that state Zantac has a high level of NDMA.
In September 2019, the US Food and Drug Administration (FDA) announced it had found traces of NDMA in Zantac and Zantac was recalled after the traces of NDMA found in Zantac.
According to past studies, NDMA is linked to several cancers including colon and rectum, kidneys, liver, and stomach cancer.
After dozens of complaints against the makers of heartburn medication Zantac were filed, the U.S. Judicial Panel on Multidistrict Litigation has now scheduled to hear oral arguments later this month.
[rumble video_id=vvpwd domain_id=u7nb2]